Clinical Trial Update: Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and feasibility of autologous EBV-specific cytotoxic T lymphocytes in patients with a first clinical episode highly suggestive of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Autologous EBV-specific cytotoxic T lymphocytes (EBV-specific cytotoxic T lymphocytes)

Snippet

Sponsor: Nantes University Hospital | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING